However, increased TGF-β1 levels were correlated with the presence of metastasis, arising as a new potential metastatic biomarker for CCA (cut-off value: 48.95 ng/mL; sensitivity: 48.2% and specificity: 88.9%) [88]. Here, TGFB1 is linked to cholangiocarcinoma.